Ken Griffin Zomedica Corp. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Zomedica Corp. stock. As of the latest transaction made, Citadel Advisors LLC holds 743,107 shares of ZOM stock, worth $111,466. This represents 0.0% of its overall portfolio holdings.
Number of Shares
743,107
Previous 816,597
9.0%
Holding current value
$111,466
Previous $163,000
31.9%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ZOM
# of Institutions
94Shares Held
84.1MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA48.3MShares$7.25 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA10.1MShares$1.52 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.86MShares$1.48 Million0.0% of portfolio
-
State Street Corp Boston, MA3.11MShares$466,5870.0% of portfolio
-
Brown Brothers Harriman & CO New York, NY2.47MShares$369,9790.0% of portfolio
About Zomedica Corp.
- Ticker ZOM
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 979,950,016
- Market Cap $147M
- Description
- Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...